← Leaderboards
Darrell H. Carney
Chrysalis Biotherapeutics, Inc.
$3,043,203
Attributed
$6,086,405
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–18$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,086,405 · 2
By mechanism
R44$5,789,079 · 1
R43$297,326 · 1
Top collaborators
- Laurie E Sower5 shared
- Barbara Maria Olszewska-Pazdrak2 shared
Most similar at Chrysalis Biotherapeutics, Inc.
Same institution · by research overlap
- Laurie E Sower$2,394,540
- Barbara Maria Olszewska-Pazdrak$648,663
- Barbara Olszewska-Pazdrak$199,757
Others in their field
Top investigators on “Radiation Effect”
- Philip J Disaia · University Of California Irvine$126,135,051
- Richard L Schilsky · University Of Chicago$118,786,634
- Maury Tigner · Cornell University$99,355,712
- Daniel R Marlow · University Of California-Los Angeles$64,882,770
- Monica M Bertagnolli · Strang Cancer Prevention Center$64,023,016
- Polly Chang · Sri International$53,674,299
Research focus
Radiation EffectLifeNuclearRadiationSepsisDoseExposure ToInjection Of Therapeutic AgentPhase 1 StudyPreventEmergency SituationSafetyPharmaceutical PreparationsPeptidesAcetatesCessation Of LifeHealingClinical TrialsAnimal RuleDermalAnimalsAnimal EfficacyDisastersBiological Availability
Grant awards (7)
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2018 · AI
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2017 · AI
TP508: A New Drug for Mitigating Lethals Effects of Radiation Exposure$1,000,000
R44 · FY2016 · AI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$978,663
R44 · FY2014 · AI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$810,416
R44 · FY2013 · AI
TP508: A New Drug for Mitigating Lethal Effects of Radiatin Exposure$1,000,000
R44 · FY2012 · AI
TP508:A New Drug for Mitigating Lethal Effects of Radiation Exposure$297,326
R43 · FY2010 · AI